8582 Results
1

Medscape: New adjuvant boosts SARS-CoV-2 protection in animal models

March 15, 2021

Carl Fichtenbaum, MD, of the UC College of Medicine Division of Infectious Diseases, was featured as an expert source in a story on Medscape about animal model research showing that a new adjuvant, or ingredient, added to COVID-19 vaccines has shown promise for its ability to deliver the vaccine directly into lymph nodes.

2

Livestrong: How bad is it really to snore?

March 16, 2021

Ann Romaker, MD, of the Division of Pulmonary, Critical Care and Sleep Medicine is widely quoted in an article on Livestrong.com about the potential health challenges posed by snoring. She says there is evidence that loud snoring could lead to stroke.

3

Medscape: Recombinant IFN plus antivirals may boost COVID-19 recovery versus traditional IFN

March 24, 2021

Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was one of the sources quoted in an article for Reuters Health on a study showing that in patients with moderate-severe COVID-19, recombinant super-compound interferon plus baseline antivirals was associated with a shorter time to clinical improvement than the same regimen using traditional interferon-alpha in an exploratory trial in China. Fichtenbaum said a lot more data and proof is needed before he would use this. And the lack of a control group that got just standard of care is a big weakness of this study.

6

WCPO: After 35 years of surviving HIV and AIDS, Carl Fox is part of a study he believes will find a cure

December 1, 2020

Northern Kentucky businessman Carl Fox is taking part in UC's Trailblazer study and is telling his story to WCPO-TV, Channel 9. The TRAILBLAZER study aims to change the parts of a patient’s white blood cells that HIV latches onto, and is led by Dr. Carl Fichtenbaum, a professor in the Division of Infectious Diseases in the Department of Internal Medicine at the University of Cincinnati College of Medicine.